Streptococcus pneumoniae polysaccharide antigens — Drug Target

All drugs that target Streptococcus pneumoniae polysaccharide antigens — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Vaccine · Pneumococcal conjugate vaccine

Phase 3 pipeline (2)

• Prevenar and Pneumo23 · Hospital Universitari Son Dureta · Vaccine · Immunology / Infectious Disease
  Prevenar and Pneumo23 are pneumococcal conjugate and polysaccharide vaccines that stimulate the immune system to produce antibodies against Streptococcus pneumoniae.
• Prevenar (Wyeth) · GlaxoSmithKline · Pneumococcal conjugate vaccine · Immunology / Infectious Disease
  Prevenar is a pneumococcal conjugate vaccine that stimulates the immune system to produce antibodies against Streptococcus pneumoniae serotypes.